Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1804 of 6351
-
Can tailored rehabilitation ease common childhood illnesses in uzbekistan?
Knowledge-focused By invitation onlyThe goal of the clinical study is to clarify the course of common congenital, infectious, and non-infectious diseases in children living in Uzbekistan, and to develop methods for their treatment and rehabilitation. The main questions it aims to answer: * Analysis of common cong…
Early phase 1 • Sponsor: Tashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New Antibody-Drug conjugate STRO-002 tested in advanced cancers
Disease control CompletedThis is a multi-center, open-label, monotherapy dose escalation, PK bridging, and dose expansion Phase I/IIa study in Chinese adult subjects to evaluate the safety, tolerability, Pharmacokinetics (PK) profiles, immunogenicity, and preliminary efficacy of STRO-002 in patients with…
Phase 1/2 • Sponsor: Tasly Pharmaceutical Group Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Simple saltwater solution may shield kidneys after heart transplant
Prevention Recruiting nowThe goal of this study is to evaluate if hypertonic saline solution can prevent or attenuate acute kidney injury after heart transplantation in the early postoperative phase.
Phase 2 • Sponsor: Fernando Bacal • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
10-Week therapy aims to curb impulsive behaviors in young BPD patients
Symptom relief Recruiting nowBorderline personality disorder (BPD) is a severe, high-suicidal psychiatric disorder associated with impulsive, endangering behaviors. Young patients between 16 and 25 years old do not respond to traditional psychotherapies, which are often long and not adapted to their neurocog…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Virus cocktail takes on Antibiotic-Resistant foot infections
Disease control CompletedTP-102 is a novel bacteriophage cocktail comprised of 5 (five) lytic bacteriophages against Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii. TP-102 is being developed for topical treatment of patients with wound infections including chronic ulcers; appl…
Phase 2 • Sponsor: Technophage, SA • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could a new pill calm brain inflammation and slow Parkinson's-Linked sleep disorder?
Disease control OngoingThis study is to investigate the safety and efficacy of PXS-4728A as an intervention therapy in participants with iRBD. This study will be conducted in participants aged 50 to 80 years of age and will investigate a single dose level.
Phase 2 • Sponsor: Syntara • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Pen and paper therapy: new study aims to stop PTSD after traumatic birth
Prevention CompletedThe goal of this clinical trial is to test a brief psychological intervention given to individuals in the first days following childbirth who have experienced a potentially stressful childbirth. The treatment is aimed at preventing post-traumatic stress disorder following childbi…
Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated Aug 01, 2026 00:00 UTC
-
VR adventure could spare kids from anesthesia during MRI
Symptom relief Recruiting nowThe goal of this randomized controlled trial is to evaluate whether a virtual reality based preparation method can efficiently decrease the proportion of children requiring general anesthesia during MRI examinations. Participants will take part in a virtual reality environment r…
Sponsor: Semmelweis University • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New heart procedure could cut ablation time in half
Disease control Recruiting nowThis study aims to investigate the effect of reducing ablation time for a hybrid approach of vHPSD and AI-guided ablation using the QDOT Micro catheter in PVI among patients with PAF.
Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Kidney transplant trial tests which drug better prevents rejection
Disease control Recruiting nowInduction therapy decreases the rate of acute allograft rejection in kidney transplant recipients (KTRs) and is strongly recommended. Polyclonal lymphocyte-depleting antibodies and interleukin-2 receptor (IL2R) antagonists are therefore widely used around the world, with a leadin…
Phase 3 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New cancer drug MBRC-101 enters human trials for Hard-to-Treat tumors
Disease control Recruiting nowThis is a first-in-human (FIH), open label Phase 1/1b / Phase 2 study in patients with advanced metastatic solid tumors refractory to standard treatment. Phase 1 will identify potential optimal biologically relevant doses (OBRD) and the maximum tolerated dose (MTD) of MBRC-101 at…
Phase 1/2 • Sponsor: MBrace Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New hope for stiff heart? drug trial targets common heart failure
Disease control OngoingThe purpose of this study is to evaluate the safety, tolerability, and exposure-response (E-R) of BMS-986435/MYK-224 in participants with symptomatic Heart Failure with Preserved Ejection Fraction (HFpEF).
Phase 2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New injection aims to shrink skin tumors before surgery
Disease control OngoingThe goal of this clinical trial is to evaluate the safety and tolerability of intratumoral injections of PH-762 in squamous cell carcinoma, melanoma, or Merkel cell carcinomas of the skin, to understand what the body does to the PH-762, and to observe how the tumor responds to th…
Phase 1 • Sponsor: Phio Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug combo takes on Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis Phase 1 first-in-human study will investigate the safety, tolerability, pharmacokinetics (PK), immunogenicity, and preliminary antitumor activity of JZP898 monotherapy as well as JZP898 in combination with pembrolizumab in adult participants with advanced or metastatic solid…
Phase 1 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New surgical technique aims to reduce cancer margins in vulvar dysplasia
Disease control OngoingThe purpose of this study is to compare "Frozen-Section Directed Excision", which has been a proven method of surgery used in dermatology, versus the current, standard method called "Wide Local Excision" to treat high-grade vulvar dysplasia.
Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Herbal gout treatment shows promise in large trial
Symptom relief CompletedThis study will evaluate the efficacy and safety of Qingzhu Granules in the treatment of Acute Gouty Arthritis ( Damp heat pattern)
Phase 3 • Sponsor: Tasly Pharmaceutical Group Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Do RSV vaccines work as well in nursing homes? new study investigates
Vaccine CompletedThis clinical trial is studying the newly licensed RSV vaccines in adults over age 60 years living in long-term care facilities (nursing homes) by comparing the immune response to their vaccine to adults over age 60 years living in the community.
Phase 4 • Sponsor: University of Rochester • Aim: Vaccine
Last updated Jun 27, 2026 07:55 UTC
-
Can a tree mushroom drink calm inflammatory bowel disease?
Disease control CompletedThis open-label pilot study aims to evaluate the safety and efficacy of the dietary supplement Good Feeling Power® for patients with mild-to-moderate ulcerative colitis and colonic/ileal Crohn's disease.
Sponsor: Good Feeling Products GmbH • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Scent of sleep: herbal sachet may offer Drug-Free relief for insomnia in seniors
Symptom relief CompletedThe goal of this clinical trial was to determine whether nightly exposure to a Traditional Chinese Medicine herbal sachet could reduce insomnia symptoms and improve sleep quality in adults aged 60 years or older. Participants residing in five community-based integrated medical an…
Sponsor: Macao Polytechnic University • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
New pill shows promise for MS control in early trial
Disease control CompletedThis is a randomized, double-blind study of PIPE-307 or placebo in subjects with relapsing-remitting multiple sclerosis. Subjects will be randomized into 1 of 3 separate cohorts (1:1:1 randomization ratio, PIPE-307 Dose A:PIPE-307 Dose B: Placebo) for a total duration of approxim…
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC